Summary of Community Health Systems (CYH) Q4 2025 Earnings Call

1Key Financial Results and Metrics

Adjusted EBITDA: $395 million for Q4 2025, with a margin of 12.7%. Adjusted EBITDA was slightly up year-over-year.

Same-store Net Revenue: Increased by 2.1% year-over-year, driven by a 2.4% rise in net revenue per adjusted admission.

Same-store Admissions: Down 0.3%, with same-store surgeries declining by 1.9% and ED visits down 3.6%.

Cash Flows from Operations: $266 million for Q4, totaling $543 million for the full year, up from $480 million in 2024.

Leverage Ratio: Improved to 6.6x at year-end 2025 from 7.4x at year-end 2024.

2Strategic Updates and Business Highlights

Divestitures: CHS completed several divestitures in 2025, allowing reinvestment into core operations and debt reduction. Notable divestitures included Tennova Healthcare, Clarksville for $623 million and Pennsylvania hospitals for $33 million.

Capital Investments: Significant investments in emergency room expansions and women's services led to increased patient volumes in specific locations, such as a 20% increase in births at Grandview Medical Center.

Operational Improvements: Focus on cost controls, with labor costs managed effectively. Medical specialist fees increased by 4.6% year-over-year.

Technology Initiatives: Successful ERP implementation and AI integration aimed at improving operational efficiencies and revenue cycle management.

3Forward Guidance and Outlook

2026 Financial Guidance: Anticipated net revenue between $11.6 billion to $12.0 billion, adjusted EBITDA of $1.34 billion to $1.49 billion, and cash flows from operations of $600 million to $700 million.

Volume Growth Expectations: Low single-digit same-store volume growth anticipated for 2026, with a stronger second half expected due to improved consumer confidence and commercial payer mix.

4Bad News, Challenges, or Points of Concern

Volume Declines: Same-store admissions and surgeries have decreased, indicating potential challenges in patient volume recovery.

Regulatory and Economic Disruptions: Ongoing uncertainties in reimbursement and insurance coverage, particularly related to health care exchanges, which could impact revenue and profitability.

Cost Pressures: Anticipated upward pressure on medical specialist fees and potential negative impacts from changes in health insurance exchange enrollment, estimated to reduce EBITDA by $20 million to $30 million.

5Notable Q&A Insights

Divestiture Strategy: Management indicated they are nearing the end of their programmatic divestitures, focusing on maintaining a strong portfolio while being opportunistic about future transactions.

Consumer Confidence: A dip in consumer confidence was noted, with expectations for recovery throughout 2026, particularly in commercial payer volumes.

Technology Investments: Continued focus on AI applications in operational efficiencies and revenue optimization, with ongoing improvements expected from the new ERP system.

Impact of ACA Changes: Management discussed the potential impacts of ACA-related changes on enrollment and revenue, emphasizing a cautious but optimistic approach to managing these challenges. This summary encapsulates the key points from the earnings call, providing a balanced view of Community Health Systems' performance, strategic direction, and challenges ahead.